Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 19, 2026.

The Intestinal Microbiota in Metabolic Disease

Anni Woting, Michael Blaut

Nutrients · 2016 · Review · CC BY

doi:10.3390/nu8040202

Abstract

Gut bacteria exert beneficial and harmful effects in metabolic diseases as deduced from the comparison of germfree and conventional mice and from fecal transplantation studies. Compositional microbial changes in diseased subjects have been linked to adiposity, type 2 diabetes and dyslipidemia. Promotion of an increased expression of intestinal nutrient transporters or a modified lipid and bile acid metabolism by the intestinal microbiota could result in an increased nutrient absorption by the host. The degradation of dietary fiber and the subsequent fermentation of monosaccharides to short-chain fatty acids (SCFA) is one of the most controversially discussed mechanisms of how gut bacteria impact host physiology. Fibers reduce the energy density of the diet, and the resulting SCFA promote intestinal gluconeogenesis, incretin formation and subsequently satiety. However, SCFA also deliver energy to the host and support liponeogenesis. Thus far, there is little knowledge on bacterial species that promote or prevent metabolic disease. Clostridium ramosum and Enterococcus cloacae were demonstrated to promote obesity in gnotobiotic mouse models, whereas bifidobacteria and Akkermansia muciniphila were associated with favorable phenotypes in conventional mice, especially when oligofructose was fed. How diet modulates the gut microbiota towards a beneficial or harmful composition needs further research. Gnotobiotic animals are a valuable tool to elucidate mechanisms underlying diet–host–microbe interactions.

References 117

  1. 1.

    Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484.

    Not in our library10.1038/nature07540

  2. 2.

    Hildebrandt M.A., Hoffmann C., Sherrill-Mix S.A., Keilbaugh S.A., Hamady M., Chen Y.Y., Knight R., Ahima R.S., Bushman F., Wu G.D. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137.

    Not in our library10.1053/j.gastro.2009.08.042

  3. 3.

    Murphy E.F., Cotter P.D., Healy S., Marques T.M., O’Sullivan O., Fouhy F., Clarke S.F., O’Toole P.W., Quigley E.M., Stanton C., et al. Composition and energy harvesting capacity of the gut microbiota: Relationship to diet, obesity and time in mouse models. Gut. 2010;59:1635-1642.

    Not in our library10.1136/gut.2010.215665

  4. 4.

    Maukonen J., Simoes C., Saarela M. The currently used commercial DNA-extraction methods give different results of clostridial and actinobacterial populations derived from human fecal samples. FEMS Microbiol. Ecol. 2012;79:697-708.

    Not in our library10.1111/j.1574-6941.2011.01257.x

  5. 5.

    Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-1638.

    Not in our library10.1126/science.1110591

  6. 6.

    Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355-1359.

    Not in our library10.1126/science.1124234

  7. 7.

    Flint H.J., Scott K.P., Duncan S.H., Louis P., Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes. 2012;3:289-306.

    Not in our library10.4161/gmic.19897

  8. 8.

    D’Elia J.N., Salyers A.A. Effect of regulatory protein levels on utilization of starch by Bacteroides thetaiotaomicron. J. Bacteriol. 1996;178:7180-7186.

    Not in our library10.1128/jb.178.24.7180-7186.1996

  9. 9.

    Shipman J.A., Berleman J.E., Salyers A.A. Characterization of four outer membrane proteins involved in binding starch to the cell surface of Bacteroides thetaiotaomicron. J. Bacteriol. 2000;182:5365-5372.

    Not in our library10.1128/jb.182.19.5365-5372.2000

  10. 10.

    Ze X., Ben David Y., Laverde-Gomez J.A., Dassa B., Sheridan P.O., Duncan S.H., Louis P., Henrissat B., Juge N., Koropatkin N.M., et al. Unique Organization of Extracellular Amylases into Amylosomes in the Resistant Starch-Utilizing Human Colonic Firmicutes Bacterium Ruminococcus bromii. mBio. 2015;6.

    Not in our library10.1128/mbio.01058-15

  11. 11.

    Sonnenburg J.L., Xu J., Leip D.D., Chen C.H., Westover B.P., Weatherford J., Buhler J.D., Gordon J.I. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science. 2005;307:1955-1959.

    Not in our library10.1126/science.1109051

  12. 12.

    Turroni F., Bottacini F., Foroni E., Mulder I., Kim J.H., Zomer A., Sanchez B., Bidossi A., Ferrarini A., Giubellini V., et al. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc. Natl. Acad. Sci. USA. 2010;107:19514-19519.

    Not in our library10.1073/pnas.1011100107

  13. 13.

    Derrien M., Collado M.C., Ben-Amor K., Salminen S., de Vos W.M. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol. 2008;74:1646-1648.

    Not in our library10.1128/aem.01226-07

  14. 14.

    Sonnenburg E.D., Sonnenburg J.L., Manchester J.K., Hansen E.E., Chiang H.C., Gordon J.I. A hybrid two-component system protein of a prominent human gut symbiont couples glycan sensing in vivo to carbohydrate metabolism. Proc. Natl. Acad. Sci. USA. 2006;103:8834-8839.

    Not in our library10.1073/pnas.0603249103

  15. 15.

    Sonnenburg E.D., Zheng H., Joglekar P., Higginbottom S.K., Firbank S.J., Bolam D.N., Sonnenburg J.L. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell. 2010;141:1241-1252.

    Not in our library10.1016/j.cell.2010.05.005

  16. 16.

    Lynch J.B., Sonnenburg J.L. Prioritization of a plant polysaccharide over a mucus carbohydrate is enforced by a bacteroides hybrid two-component system. Mol. Microbiol. 2012;85:478-491.

    Not in our library10.1111/j.1365-2958.2012.08123.x

  17. 17.

    Macfarlane G.T., Macfarlane S. Factors affecting fermentation reactions in the large bowel. Proc. Nutr. Soc. 1993;52:367-373.

    Not in our library10.1079/pns19930072

  18. 18.

    Smith E.A., Macfarlane G.T. Studies on amine production in the human colon: Enumeration of amine forming bacteria and physiological effects of carbohydrate and pH. Anaerobe. 1996;2:285-297.

    Not in our library10.1006/anae.1996.0037

  19. 19.

    Smith E.A., Macfarlane G.T. Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microb. Ecol. 1997;33:180-188.

    Not in our library10.1007/s002489900020

  20. 20.

    Smith E.A., Macfarlane G.T. Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe. 1997;3:327-337.

    Not in our library10.1006/anae.1997.0121

  21. 21.

    Budnowski J., Hanske L., Schumacher F., Glatt H., Platz S., Rohn S., Blaut M. Glucosinolates are mainly absorbed intact in germfree and human microbiota-associated mice. J. Agric. Food. Chem. 2015;63:8418-8428.

    Not in our library10.1021/acs.jafc.5b02948

  22. 22.

    Luang-In V., Narbad A., Nueno-Palop C., Mithen R., Bennett M., Rossiter J.T. The metabolism of methylsulfinylalkyl- and methylthioalkyl-glucosinolates by a selection of human gut bacteria. Mol. Nutr. Food Res. 2014;58:875-883.

    Not in our library10.1002/mnfr.201300377

  23. 23.

    Braune A., Blaut M. Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes. 2016.

    Not in our library10.1080/19490976.2016.1158395

  24. 24.

    Ridlon J.M., Kang D.J., Hylemon P.B., Bajaj J.S. Bile acids and the gut microbiome. Curr. Opin. Gastroenterol. 2014;30:332-338.

    Not in our library10.1097/mog.0000000000000057

  25. 25.

    Islam K.B.M.S., Fukiya S., Hagio M., Fujii N., Ishizuka S., Ooka T., Ogura Y., Hayashi T., Yokota A. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 2011;141:1773-1781.

    Not in our library10.1053/j.gastro.2011.07.046

  26. 26.

    Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 2004;101:15718-15723.

    Not in our library10.1073/pnas.0407076101

  27. 27.

    Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA. 2007;104:979-984.

    Not in our library10.1073/pnas.0605374104

  28. 28.

    Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., Hammer R.E., Williams S.C., Crowley J., Yanagisawa M., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, GPR41. Proc. Natl. Acad. Sci. USA. 2008;105:16767-16772.

    Not in our library10.1073/pnas.0808567105

  29. 29.

    Rabot S., Membrez M., Bruneau A., Gerard P., Harach T., Moser M., Raymond F., Mansourian R., Chou C.J. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J. 2010;24:4948-4959.

    Not in our library10.1096/fj.10-164921

  30. 30.

    Fleissner C.K., Huebel N., Abd El-Bary M.M., Loh G., Klaus S., Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 2010;104:919-929.

    Not in our library10.1017/s0007114510001303

  31. 31.

    Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031.

    Not in our library10.1038/nature05414

  32. 32.

    Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009;1:6ra14.

    Not in our library10.1126/scitranslmed.3000322

  33. 33.

    Ridaura V.K., Faith J.J., Rey F.E., Cheng J., Duncan A.E., Kau A.L., Griffin N.W., Lombard V., Henrissat B., Bain J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341:1241214.

    Not in our library10.1126/science.1241214

  34. 34.

    Faith J.J., McNulty N.P., Rey F.E., Gordon J.I. Predicting a human gut microbiota’s response to diet in gnotobiotic mice. Science. 2011;333:101-104.

    Not in our library10.1126/science.1206025

  35. 35.

    David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559-563.

    Not in our library10.1038/nature12820

  36. 36.

    Carmody R.N., Gerber G.K., Luevano J.M., Gatti D.M., Somes L., Svenson K.L., Turnbaugh P.J. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe. 2015;17:72-84.

    Not in our library10.1016/j.chom.2014.11.010

  37. 37.

    Turnbaugh P.J., Backhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213-223.

    Not in our library10.1016/j.chom.2008.02.015

  38. 38.

    Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 2005;102:11070-11075.

    Not in our library10.1073/pnas.0504978102

  39. 39.

    Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006;444:1022-1023.

    Not in our library10.1038/4441022a

  40. 40.

    Furet J.P., Kong L.C., Tap J., Poitou C., Basdevant A., Bouillot J.L., Mariat D., Corthier G., Dore J., Henegar C., et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes. 2010;59:3049-3057.

    Not in our library10.2337/db10-0253

  41. 41.
  42. 42.

    Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M., Louis P., Flint H.J. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. 2008;32:1720-1724.

    Not in our library10.1038/ijo.2008.155

  43. 43.

    Schwiertz A., Taras D., Schafer K., Beijer S., Bos N.A., Donus C., Hardt P.D. Microbiota and scfa in lean and overweight healthy subjects. Obesity. 2010;18:190-195.

    Not in our library10.1038/oby.2009.167

  44. 44.

    Devkota S., Wang Y., Musch M.W., Leone V., Fehlner-Peach H., Nadimpalli A., Antonopoulos D.A., Jabri B., Chang E.B. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in il10-/- mice. Nature. 2012;487:104-108.

    Not in our library10.1038/nature11225

  45. 45.

    Samuel B.S., Gordon J.I. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc. Natl. Acad. Sci. USA. 2006;103:10011-10016.

    Not in our library10.1073/pnas.0602187103

  46. 46.

    Isken F., Klaus S., Osterhoff M., Pfeiffer A.F., Weickert M.O. Effects of long-term soluble vs. Insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice. J. Nutr. Biochem. 2010;21:278-284.

    Not in our library10.1016/j.jnutbio.2008.12.012

  47. 47.
  48. 48.

    Slavin J.L. Dietary fiber and body weight. Nutrition. 2005;21:411-418.

    Not in our library10.1016/j.nut.2004.08.018

  49. 49.
  50. 50.

    Rahat-Rozenbloom S., Fernandes J., Gloor G.B., Wolever T.M.S. Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. Int. J. Obes. 2014;38:1525-1531.

    Not in our library10.1038/ijo.2014.46

  51. 51.

    Teixeira T.F., Grzeskowiak L., Franceschini S.C., Bressan J., Ferreira C.L., Peluzio M.C. Higher level of faecal scfa in women correlates with metabolic syndrome risk factors. Br. J. Nutr. 2013;109:914-919.

    Not in our library10.1017/s0007114512002723

  52. 52.

    Weickert M.O., Arafat A.M., Blaut M., Alpert C., Becker N., Leupelt V., Rudovich N., Mohlig M., Pfeiffer A.F. Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr. Metab. 2011;8:90.

    Not in our library10.1186/1743-7075-8-90

  53. 53.

    Weickert M.O., Roden M., Isken F., Hoffmann D., Nowotny P., Osterhoff M., Blaut M., Alpert C., Gogebakan O., Bumke-Vogt C., et al. Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am. J. Clin. Nutr. 2011;94:459-471.

    Not in our library10.3945/ajcn.110.004374

  54. 54.

    Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291:881-884.

    Not in our library10.1126/science.291.5505.881

  55. 55.
  56. 56.

    Wostmann B.S. The germfree animal in nutritional studies. Annu. Rev. Nutr. 1981;1:257-279.

    Not in our library10.1146/annurev.nu.01.070181.001353

  57. 57.

    Sayin S.I., Wahlstrom A., Felin J., Jantti S., Marschall H.U., Bamberg K., Angelin B., Hyotylainen T., Oresic M., Backhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring fxr antagonist. Cell Metab. 2013;17:225-235.

    Not in our library10.1016/j.cmet.2013.01.003

  58. 58.

    Begley M., Hill C., Gahan C.G. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 2006;72:1729-1738.

    Not in our library10.1128/aem.72.3.1729-1738.2006

  59. 59.

    Semova I., Carten J.D., Stombaugh J., Mackey L.C., Knight R., Farber S.A., Rawls J.F. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe. 2012;12:277-288.

    Not in our library10.1016/j.chom.2012.08.003

  60. 60.
  61. 61.

    Wang T.Y., Liu M., Portincasa P., Wang D.Q.H. New insights into the molecular mechanism of intestinal fatty acid absorption. Eur. J. Clin. Investig. 2013;43:1203-1223.

    Not in our library10.1111/eci.12161

  62. 62.

    Voshol P.J., Rensen P.C., van Dijk K.W., Romijn J.A., Havekes L.M. Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: Studies using genetically engineered mouse models. Biochim. Biophys. Acta. 2009;1791:479-485.

    Not in our library10.1016/j.bbalip.2008.12.015

  63. 63.

    Kim I., Kim H.G., Kim H., Kim H.H., Park S.K., Uhm C.S., Lee Z.H., Koh G.Y. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 2000;346 Pt 3:603-610.

    Not in our library10.1042/bj3460603

  64. 64.

    Kersten S., Mandard S., Tan N.S., Escher P., Metzger D., Chambon P., Gonzalez F.J., Desvergne B., Wahli W. Characterization of the fasting-induced adipose factor fiaf, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 2000;275:28488-28493.

    Not in our library10.1074/jbc.m004029200

  65. 65.

    Yoon J.C., Chickering T.W., Rosen E.D., Dussault B., Qin Y., Soukas A., Friedman J.M., Holmes W.E., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell Biol. 2000;20:5343-5349.

    Not in our library10.1128/mcb.20.14.5343-5349.2000

  66. 66.

    Sukonina V., Lookene A., Olivecrona T., Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. USA. 2006;103:17450-17455.

    Not in our library10.1073/pnas.0604026103

  67. 67.

    Lichtenstein L., Kersten S. Modulation of plasma TG lipolysis by angiopoietin-like proteins and GPIHBP1. Biochim. Biophys. Acta. 2010;1801:415-420.

    Not in our library10.1016/j.bbalip.2009.12.015

  68. 68.

    Mandard S., Zandbergen F., van Straten E., Wahli W., Kuipers F., Muller M., Kersten S. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 2006;281:934-944.

    Not in our library10.1074/jbc.m506519200

  69. 69.
  70. 70.

    Blaut M., Klaus S. Intestinal microbiota and obesity. Handb. Exp. Pharmacol. 2012;251-273.

    Not in our library10.1007/978-3-642-24716-3_11

  71. 71.

    Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., Muir A.I., Wigglesworth M.J., Kinghorn I., Fraser N.J., et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003;278:11312-11319.

    Not in our library10.1074/jbc.m211609200

  72. 72.

    Xiong Y., Miyamoto N., Shibata K., Valasek M.A., Motoike T., Kedzierski R.M., Yanagisawa M. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. USA. 2004;101:1045-1050.

    Not in our library10.1073/pnas.2637002100

  73. 73.

    Tazoe H., Otomo Y., Kaji I., Tanaka R., Karaki S.I., Kuwahara A. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J. Physiol. Pharmacol. 2008;59(Suppl. 2):251-262.

    Not in our library

  74. 74.
  75. 75.

    Tolhurst G., Heffron H., Lam Y.S., Parker H.E., Habib A.M., Diakogiannaki E., Cameron J., Grosse J., Reimann F., Gribble F.M. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364-371.

    Not in our library10.2337/db11-1019

  76. 76.
  77. 77.

    Blaut M. Gut microbiota and energy balance: Role in obesity. Proc. Nutr. Soc. 2015;74:227-234.

    Not in our library10.1017/s0029665114001700

  78. 78.

    De Vadder F., Kovatcheva-Datchary P., Goncalves D., Vinera J., Zitoun C., Duchampt A., Backhed F., Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156:84-96.

    Not in our library10.1016/j.cell.2013.12.016

  79. 79.

    Delaere F., Duchampt A., Mounien L., Seyer P., Duraffourd C., Zitoun C., Thorens B., Mithieux G. The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. Mol. Metab. 2012;2:47-53.

    Not in our library10.1016/j.molmet.2012.11.003

  80. 80.

    Mithieux G. Nutrient control of energy homeostasis via gut-brain neural circuits. Neuroendocrinology. 2014;100:89-94.

    Not in our library10.1159/000369070

  81. 81.

    Wang A., Si H., Liu D., Jiang H. Butyrate activates the cAMP-protein kinase A-cAMP response element-binding protein signaling pathway in Caco-2 cells. J. Nutr. 2012;142:1-6.

    Not in our library10.3945/jn.111.148155

  82. 82.

    Hotamisligil G.S. Inflammation and metabolic disorders. Nature. 2006;444:860-867.

    Not in our library10.1038/nature05485

  83. 83.

    Cani P.D., Osto M., Geurts L., Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012;3:279-288.

    Not in our library10.4161/gmic.19625

  84. 84.

    Creely S.J., McTernan P.G., Kusminski C.M., Fisher F.M., Da Silva N.F., Khanolkar M., Evans M., Harte A.L., Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2007;292:E740-E747.

    Not in our library10.1152/ajpendo.00302.2006

  85. 85.

    Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761-1772.

    Not in our library10.2337/db06-1491

  86. 86.

    Erridge C., Attina T., Spickett C.M., Webb D.J. A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 2007;86:1286-1292.

    Not in our library10.1093/ajcn/86.5.1286

  87. 87.

    Amar J., Burcelin R., Ruidavets J.B., Cani P.D., Fauvel J., Alessi M.C., Chamontin B., Ferrieres J. Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 2008;87:1219-1223.

    Not in our library10.1093/ajcn/87.5.1219

  88. 88.

    Kitchens R.L., Thompson P.A. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 2005;11:225-229.

    Not in our library10.1177/09680519050110040701

  89. 89.

    Hersoug L.G., Moller P., Loft S. Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: Implications for inflammation and obesity. Obes. Rev. 2016;17:297-312.

    Not in our library10.1111/obr.12370

  90. 90.
  91. 91.

    Liu J., Batkai S., Pacher P., Harvey-White J., Wagner J.A., Cravatt B.F., Gao B., Kunos G. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. J. Biol. Chem. 2003;278:45034-45039.

    Not in our library10.1074/jbc.m306062200

  92. 92.

    Muccioli G.G., Naslain D., Backhed F., Reigstad C.S., Lambert D.M., Delzenne N.M., Cani P.D. The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 2010;6:392.

    Not in our library10.1038/msb.2010.46

  93. 93.

    Kless C., Muller V.M., Schuppel V.L., Lichtenegger M., Rychlik M., Daniel H., Klingenspor M., Haller D. Diet-induced obesity causes metabolic impairment independent of alterations in gut barrier integrity. Mol. Nutr. Food Res. 2015;59:968-978.

    Not in our library10.1002/mnfr.201400840

  94. 94.

    Johnson R.J., Rivard C., Lanaspa M.A., Otabachian-Smith S., Ishimoto T., Cicerchi C., Cheeke P.R., Macintosh B., Hess T. Fructokinase, fructans, intestinal permeability, and metabolic syndrome: An equine connection? J. Equine Vet. Sci. 2013;33:120-126.

    Not in our library10.1016/j.jevs.2012.05.004

  95. 95.

    Ferrer M., Ruiz A., Lanza F., Haange S.B., Oberbach A., Till H., Bargiela R., Campoy C., Segura M.T., Richter M., et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ. Microbiol. 2013;15:211-226.

    Not in our library10.1111/j.1462-2920.2012.02845.x

  96. 96.

    Karlsson F.H., Tremaroli V., Nookaew I., Bergstrom G., Behre C.J., Fagerberg B., Nielsen J., Backhed F. Gut metagenome in european women with normal, impaired and diabetic glucose control. Nature. 2013;498:99-103.

    Not in our library10.1038/nature12198

  97. 97.

    Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., Almeida M., Arumugam M., Batto J.M., Kennedy S., et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541-546.

    Not in our library10.1038/nature12506

  98. 98.

    Fei N., Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 2013;7:880-884.

    Not in our library10.1038/ismej.2012.153

  99. 99.

    Faith J.J., Ahern P.P., Ridaura V.K., Cheng J., Gordon J.I. Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci. Transl. Med. 2014;6:220ra211.

    Not in our library10.1126/scitranslmed.3008051

  100. 100.

    Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA. 2013;110:9066-9071.

    Not in our library10.1073/pnas.1219451110

  101. 101.

    Roopchand D.E., Carmody R.N., Kuhn P., Moskal K., Rojas-Silva P., Turnbaugh P.J., Raskin I. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high fat diet-induced metabolic syndrome. Diabetes. 2015;64:2847-2858.

    Not in our library10.2337/db14-1916

  102. 102.

    Dao M.C., Everard A., Aron-Wisnewsky J., Sokolovska N., Prifti E., Verger E.O., Kayser B.D., Levenez F., Chilloux J., Hoyles L., et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology. Gut. 2016;65:426-436.

    Not in our library10.1136/gutjnl-2014-308778

  103. 103.

    Shin N.R., Lee J.C., Lee H.Y., Kim M.S., Whon T.W., Lee M.S., Bae J.W. An increase in the Akkermansia spp. Population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014;63:727-735.

    Not in our library10.1136/gutjnl-2012-303839

  104. 104.

    Behnsen J., Deriu E., Sassone-Corsi M., Raffatellu M. Probiotics: Properties, examples, and specific applications. Cold Spring Harb. Perspect. Med. 2013;3:a010074.

    Not in our library10.1101/cshperspect.a010074

  105. 105.

    Million M., Angelakis E., Paul M., Armougom F., Leibovici L., Raoult D. Comparative meta-analysis of the effect of lactobacillus species on weight gain in humans and animals. Microb. Pathog. 2012;53:100-108.

    Not in our library10.1016/j.micpath.2012.05.007

  106. 106.
  107. 107.

    Wu C.C., Weng W.L., Lai W.L., Tsai H.P., Liu W.H., Lee M.H., Tsai Y.C. Effect of Lactobacillus plantarum strain K21 on high-fat diet-fed obese mice. Evid. Based Complement. Altern. Med. 2015;2015:391767.

    Not in our library10.1155/2015/391767

  108. 108.

    Kadooka Y., Sato M., Ogawa A., Miyoshi M., Uenishi H., Ogawa H., Ikuyama K., Kagoshima M., Tsuchida T. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br. J. Nutr. 2013;110:1696-1703.

    Not in our library10.1017/s0007114513001037

  109. 109.

    Collado M.C., Isolauri E., Laitinen K., Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am. J. Clin. Nutr. 2008;88:894-899.

    Not in our library10.1093/ajcn/88.4.894

  110. 110.

    Kalliomaki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 2008;87:534-538.

    Not in our library10.1093/ajcn/87.3.534

  111. 111.

    Wu X., Ma C., Han L., Nawaz M., Gao F., Zhang X., Yu P., Zhao C., Li L., Zhou A., et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 2010;61:69-78.

    Not in our library10.1007/s00284-010-9582-9

  112. 112.

    Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374-2383.

    Not in our library10.1007/s00125-007-0791-0

  113. 113.

    Cani P.D., Knauf C., Iglesias M.A., Drucker D.J., Delzenne N.M., Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes. 2006;55:1484-1490.

    Not in our library10.2337/db05-1360

  114. 114.

    Woting A., Pfeiffer N., Hanske L., Loh G., Klaus S., Blaut M. Alleviation of high fat diet-induced obesity by oligofructose in gnotobiotic mice is independent of presence of bifidobacterium longum. Mol. Nutr. Food Res. 2015;59:2267-2278.

    Not in our library10.1002/mnfr.201500249

  115. 115.

    Kondo S., Xiao J.Z., Satoh T., Odamaki T., Takahashi S., Sugahara H., Yaeshima T., Iwatsuki K., Kamei A., Abe K. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci. Biotechnol. Biochem. 2010;74:1656-1661.

    Not in our library10.1271/bbb.100267

  116. 116.

    Stenman L.K., Waget A., Garret C., Klopp P., Burcelin R., Lahtinen S. Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Benef. Microbes. 2014;5:437-445.

    Not in our library10.3920/bm2014.0014

  117. 117.

    Minami J., Kondo S., Yanagisawa N., Odamaki T., Xiao J.Z., Abe F., Nakajima S., Hamamoto Y., Saitoh S., Shimoda T. Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial. J. Nutr. Sci. 2015;4:e17.

    Not in our library10.1017/jns.2015.5

Cited by papers we hold 13

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.